
Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings, Inc.(AMBS)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · AMBS · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Amarantus BioScience Holdings, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
近期内幕交易记录
AMBS 高管卖出股份 · AMBS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 1, 2016 | COMMISSIONG GERALD CEO · Director | Other | 45,283 | $12K | Form 4 |
| Apr 9, 2015 | FARRELL ROBERT EDWARD CFO | Purchase | 200,000 | $10K | Form 4 |
| Apr 8, 2015 | COMMISSIONG GERALD CEO · Director | Purchase | 203,000 | $10K | Form 4 |
| Apr 8, 2015 | COMMISSIONG GERALD CEO · Director | Purchase | 37,000 | $2K | Form 4 |
| Nov 19, 2014 | FARRELL ROBERT EDWARD CFO · Director | Purchase | 133,333 | $10K | Form 4 |
| Nov 20, 2014 | COMMISSIONG GERALD CEO · Director | Purchase | 10,000 | $768 | Form 4 |
| Nov 20, 2014 | COMMISSIONG GERALD CEO · Director | Purchase | 36,000 | $3K | Form 4 |
| Nov 20, 2014 | COMMISSIONG GERALD CEO · Director | Purchase | 84,000 | $6K | Form 4 |
| Jan 17, 2014 | COMMISSIONG GERALD CEO · Director | Purchase | 50,000 | $5K | Form 4 |
| Apr 30, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 50,000 | $3K | Form 4 |
| Feb 21, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 50,000 | $4K | Form 4 |
| Feb 5, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 2,100 | $176 | Form 4 |
| Feb 5, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 47,900 | $4K | Form 4 |
| Jan 14, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 15,000 | $1K | Form 4 |
| Jan 11, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 15,000 | $1K | Form 4 |
| Jan 11, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 10,000 | $742 | Form 4 |
| Jan 11, 2013 | COMMISSIONG GERALD CEO · Director | Purchase | 10,000 | $887 | Form 4 |
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AMBS 内幕交易
AMBS 内幕交易
Amarantus BioScience Holdings, Inc.(AMBS)内幕交易数据来源于公司内部人(包括AMBS)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。AMBS内部人近期买卖活动混合,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Amarantus BioScience Holdings, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
AMBS 内幕交易 · 5个问题Amarantus BioScience Holdings, Inc.(AMBS)的内部人包括高管和董事,如AMBS等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026